N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide

C104H85BrClFN16O5 — CID 159315155

IUPACN-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide
SMILESNc1ccc(-c2cnc(NC(=O)Cc3ccc(Br)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(Cl)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(F)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(O)cc3)c(/C=C/c3ccccc3)n2)cc1
InChIInChI=1S/C26H21BrN4O.C26H21ClN4O.C26H21FN4O.C26H22N4O2/c3*27-21-11-6-19(7-12-21)16-25(32)31-26-23(15-8-18-4-2-1-3-5-18)30-24(17-29-26)20-9-13-22(28)14-10-20;27-21-11-9-20(10-12-21)24-17-28-26(23(29-24)15-8-18-4-2-1-3-5-18)30-25(32)16-19-6-13-22(31)14-7-19/h3*1-15,17H,16,28H2,(H,29,31,32);1-15,17,31H,16,27H2,(H,28,30,32)/b4*15-8+
InChIKeyLDATYJPCZPFFKB-XHUILMAHSA-N
MW1773.29 g/mol
LogP21.57
Rot. Bonds24

About N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide

N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide (PubChem CID 159315155) has the molecular formula C104H85BrClFN16O5 and a molecular weight of 1773.29 g/mol. Its IUPAC name is N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide.

Molecular Properties

Compound NameN-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide
PubChem CID159315155
Molecular FormulaC104H85BrClFN16O5
Molecular Weight1773.29 g/mol
Exact Mass1770.57
IUPAC NameN-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide
SMILESNc1ccc(-c2cnc(NC(=O)Cc3ccc(Br)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(Cl)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(F)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(O)cc3)c(/C=C/c3ccccc3)n2)cc1
InChIInChI=1S/C26H21BrN4O.C26H21ClN4O.C26H21FN4O.C26H22N4O2/c3*27-21-11-6-19(7-12-21)16-25(32)31-26-23(15-8-18-4-2-1-3-5-18)30-24(17-29-26)20-9-13-22(28)14-10-20;27-21-11-9-20(10-12-21)24-17-28-26(23(29-24)15-8-18-4-2-1-3-5-18)30-25(32)16-19-6-13-22(31)14-7-19/h3*1-15,17H,16,28H2,(H,29,31,32);1-15,17,31H,16,27H2,(H,28,30,32)/b4*15-8+
InChIKeyLDATYJPCZPFFKB-XHUILMAHSA-N
XLogP21.57
TPSA343.83 Ų
H-Bond Donors9
H-Bond Acceptors17
Rotatable Bonds24
Heavy Atoms128
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001773.29
LogP ≤ 521.57
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide?
The IUPAC name of N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide (CID 159315155) is N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide.
What is the SMILES notation for N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide?
The canonical SMILES for N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide is Nc1ccc(-c2cnc(NC(=O)Cc3ccc(Br)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(Cl)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(F)cc3)c(/C=C/c3ccccc3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc(O)cc3)c(/C=C/c3ccccc3)n2)cc1.
What is the InChIKey of N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide?
The InChIKey is LDATYJPCZPFFKB-XHUILMAHSA-N. The full InChI is InChI=1S/C26H21BrN4O.C26H21ClN4O.C26H21FN4O.C26H22N4O2/c3*27-21-11-6-19(7-12-21)16-25(32)31-26-23(15-8-18-4-2-1-3-5-18)30-24(17-29-26)20-9-13-22(28)14-10-20;27-21-11-9-20(10-12-21)24-17-28-26(23(29-24)15-8-18-4-2-1-3-5-18)30-25(32)16-19-6-13-22(31)14-7-19/h3*1-15,17H,16,28H2,(H,29,31,32);1-15,17,31H,16,27H2,(H,28,30,32)/b4*15-8+.
What are the key properties of N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide?
N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide has a molecular weight of 1773.29 g/mol, XLogP of 21.57, 24 rotatable bonds, 9 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-bromophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-chlorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-fluorophenyl)acetamide;N-[5-(4-aminophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-(4-hydroxyphenyl)acetamide is sourced from PubChem (CID 159315155), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).